U.S. FDA approves Johnson & Johnson's bladder cancer drug
The U.S. Food and Drug Administration on Friday approved Johnson & Johnson's treatment for patients with a form of bladder cancer.
from Reuters: Health News https://reut.rs/2X44asA
http://bit.ly/2zwRqiM
April 12, 2019 | Labels: health, Reuters: Health News |
This entry was posted on April 12, 2019 and is filed under health , Reuters: Health News . You can follow any responses to this entry through the RSS 2.0 feed. or trackback from your own site.